Toggle navigation
Home
People
Departments
Research
About
Login
Search
Histone variant H2A.Z as a novel therapeutic target for Alzheimer's disease
Grant
Overview
Affiliation
View All
Overview
date/time interval
April 1, 2018 - March 31, 2023
awarded by
Canadian Institutes of Health Research
total award amount
CAD 976196
Affiliation
contributor
Fahnestock, Margaret
Funded by